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Abstract
Calorie restriction (CR), an age delaying diet, affects fat oxidation through poorly
understood mechanisms. We investigated the effect of CR on fat metabolism gene
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expression and intermediate metabolites of fatty acid oxidation in the liver. We found
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nitines, and long-chain 3-hydroxy-acylcarnitines increased, and several long-chain

Funding information
U.S. National Institutes of Health/
National Institute on Aging, Grant/Award
Number: R01AG039547; Center for
Gene Regulation in Health and Disease
(Cleveland State University)

that CR changed the liver acylcarnitine profile: acetylcarnitine, short-chain acylcaracylcarnitines decreased. Acetyl-CoA and short-chain acyl-CoAs were also increased
in CR. CR did not affect the expression of CPT1 and upregulated the expression of
long-chain and very-long-chain Acyl-CoA dehydrogenases (LCAD and VLCAD, respectively). The expression of downstream enzymes such as mitochondrial trifunctional protein and enzymes in medium- and short-chain acyl-CoAs oxidation was not
affected in CR. CR shifted the balance of fatty acid oxidation enzymes and fatty acid
metabolites in the liver. Acetyl-CoA generated through beta-oxidation can be used
for ketogenesis or energy production. In agreement, blood ketone bodies increased
under CR in a time of the day-dependent manner. Carnitine acetyltransferase (CrAT)
is a bidirectional enzyme that interconverts short-chain acyl-CoAs and their corresponding acylcarnitines. CrAT expression was induced in CR liver supporting the
increased acetylcarnitine and short-chain acylcarnitine production. Acetylcarnitine
can freely travel between cellular sub-compartments. Supporting this CR increased
protein acetylation in the mitochondria, cytoplasm, and nucleus. We hypothesize that
changes in acyl-CoA and acylcarnitine levels help to control energy metabolism and
contribute to metabolic flexibility under CR.
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aging, CR, and the circadian clock (Makwana et al., 2019; Patel et al.,
2016; Sato et al., 2017). Therefore, the circadian rhythms must be

Increased incidence of metabolic diseases is a significant challenge

taken into consideration to understand CR-induced reprogramming

for modern society. Metabolic syndrome contributes to the devel-

of fat metabolism.

opment of diabetes, cardiovascular diseases, and cancer (Bonomini

It is hypothesized that fat oxidation is increased in CR (Anderson

et al., 2015; Muoio, 2014). Disruption in lipid homeostasis is one

& Weindruch, 2010), and the shift in preference for substrate oxi-

of the hallmarks of metabolic and age related diseases (Johnson &

dation is in line with this hypothesis (Bruss et al., 2010). However,

Stolzing, 2019; Savage et al., 2007). Diet is recognized as an import-

molecular events associated with fat oxidation in CR tissues are

ant factor affecting disease development and progression. Caloric

mostly unknown. Acylcarnitines are intermediate metabolites in

restriction (CR), a reduction in food intake without malnutrition, is

beta-oxidation, and analysis of tissue and blood levels of acylcarni-

one of the dietary interventions known to have a universally positive

tines is a widely accepted method for evaluating fatty acid oxidation

effect on metabolism in animal models and humans (Longo et al.,

(El-Gharbawy & Vockley, 2018; Rinaldo et al., 2008). Acylcarnitine

2015). Multiple cellular and physiological systems are affected by

profiling has not been performed in mice on CR across the day. Here,

CR, and some of these changes may contribute to CR-induced met-

we compared acyl-CoAs, acylcarnitines, and the expression of fatty

abolic health benefits. Shift in energy metabolism is a recognized

acid metabolism enzymes across the day in the liver of mice on AL

metabolic adaptation to limited nutrient resources available under

and CR diets. We found that some acylcarnitines oscillated during

CR (Anderson & Weindruch, 2010). Judged by respiratory exchange

the day suggesting their production may be regulated by diet and the

ratio, AL fed rodents predominantly oxidize carbohydrates around

clock. CR increased expression of several fat catabolism enzymes

the clock, in contrast with that, CR animals change substrate pref-

such as carnitine palmitoyl transferase 2 (CPT2), VLCAD, and LCAD,

erence through the day: First few hours after the meal, they oxidize

while CPTI and many downstream enzymes such as mitochondrial

carbohydrates; then, they gradually switch to fatty acid oxidation

trifunctional protein (MTP), medium-chain acyl-CoA dehydrogenase

until the next meal (Bruss et al., 2010). The shift in energy metab-

(MCAD), short-chain acyl-CoA dehydrogenase (SCAD), and ace-

olism may be linked with changes in the feeding pattern of CR an-

tyl-CoA acyl transferase 2 (ACAA2) were not affected. Surprisingly,

imals. AL fed animals eat around the clock. CR animals, which are

levels of short-chain acyl-CoAs (acetyl-CoA, C4-CoA and C6-CoA)

usually fed once per day at the same time, consume the entire meal

and corresponding acylcarnitines were significantly increased in

in roughly 2 h and fast for the next 21–23 h. (Acosta-Rodríguez

the CR liver. Accumulation of energy rich short-chain acyl-CoAs,

et al., 2017; Bruss et al., 2010; Patel et al., 2016; Velingkaar et al.,

especially acetyl-CoA, under limited resources of CR diet was coun-

2020). Changes in fat metabolism under CR have been reported in

terintuitive and suggests that they may play additional roles in the

Drosophila suggesting a conservative response (Katewa et al., 2016).

mechanisms of CR. We hypothesize that changes in fatty acid oxi-

Fatty acids are oxidized through a chain of reactions that re-

dation and production of acetyl-CoA/acetylcarnitine pools coordi-

quire coordinated activity of several enzymes, which expression and

nate metabolic processes in the liver and may contribute to health

activity in the liver and other tissues are affected by dietary inter-

benefits of CR.

ventions (Barger et al., 2015; Eckel-Mahan et al., 2013; Kuhla et al.,
2014). Little is known if the expression of fatty acid oxidation enzymes is affected in CR. Protein expression has not been reported
in CR, and there are several transcriptomic studies with mixed outcomes (reviewed in (Swindell, 2009). Discrepancy of results from

2
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R E S U LT S

2.1 | CR affected liver acylcarnitine profiles

different reports may be due to different times of feeding for the
experiment and analysis of RNA. The feeding/oxidation cycle has

To study the effect of diet on fatty acid oxidation, CR was imple-

24-h periodicity, which implies a possible interaction with circadian

mented to 3-month old C57B6/J mice. CR mice received 70% of

rhythms, and this is supported by evidence of a crosstalk between

AL food intake to achieve 30% CR for 2 months. CR mice received

F I G U R E 1 CR increased short-chain acylcarnitines in the liver. (a) Fold changes in daily average level of short-chain (left panel), mediumchain (middle panel), and long-chain (right panel) acylcarnitines in CR liver (n = 24 per diet). Daily average of acylcarnitines in AL liver were
set as one, shown as dashed line. Acylcarnitine species are annotated as following [number of carbon atoms]:[number of double bonds].
(b) Daily rhythms of several acylcarnitines in the liver of AL (blue diamonds) and CR (red circles) mice (data represented as average±STD,
n = 4 per time point per diet). (c) Relative changes in free and total carnitine and ratio of free to total carnitine in AL (blue) and CR (red).
(d) Daily rhythms of free carnitine (data represented as average±STD, n = 4 per time point per diet). (e) Phase distribution of rhythmic
acylcarnitines, AL (blue) and CR (red). (f) Daily rhythms in the expression of circadian clock genes Bmal1, Per2, and Per1 (data represented
as average±STD, n = 3 per time point per diet). (g) Daily rhythms in ribosomal protein S6 phosphorylation and (h) representative Western
blot and quantification (data represented as average±STD, n = 3 per time point per diet). *—statistically significant difference, p < 0.05, by
t test. #—statistically significant effect of diet, p < 0.05, two-way ANOVA. Shadowed area on the graphs or dark bar above the Western
blot represents dark phase of the day, the light was on at ZT0, and the light was off at ZT12. Table S1 contains statistics from ANOVA and
student's t test for acylcarnitines. Tables S2 and S3 contain statistics for 24-h and 12-h rhythm analysis for acylcarnitines, respectively
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food at ZT14, 2 h after the light is turned off, which corresponds

30.6 ± 2.6 g for AL mice and 25.4 ± 1.9 g for CR mice. Blood glucose

to the regular feeding time for AL mice. As expected, CR resulted

was also significantly reduced: 173.4 ± 11.5 mg/dl for AL mice and

in significantly reduced body weight: Average body weight was

116.9 ± 13.1 mg/dl for CR mice. After two months of CR, tissues
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were harvested for the analysis of gene expression and intermedi-

with peaks around the beginning (ZT0) and end (ZT12) of the light

ate metabolites in fatty acid oxidation such as acylcarnitines and

period (Table S3 and Figure S2B). Under CR, only three long-chain

acyl-CoA. Fat metabolism is known to be affected by time of feed-

acylcarnitines were rhythmic with a 12-h period (Table S3 and Figure

ing and by the circadian clock (Adamovich et al., 2015; Loizides-

S2B). Free carnitine followed 12-h rhythms in AL and 24-h rhythms

Mangold et al., 2017). Therefore, acylcarnitines were analyzed at 6

in CR liver (Figure 1d,e and Figure S2B). Thus, changes in period of

time points around the clock. We assayed acylcarnitines in the liver

acylcarnitine oscillation agreed with changes in food intake pattern.

of AL and CR mice using LC-MS/MS. CR has two main effects on

Circadian clock is implicated in the control of fatty acid metab-

acylcarnitine profiles. First, CR significantly affected the level of

olism (Adamovich et al., 2015; Loizides-Mangold et al., 2017). We

acylcarnitines, daily averages for short-, medium-, and long-chain

assayed rhythms in mRNA for circadian clock genes. As it was ex-

acylcarnitines are shown in Figure 1a (relative change) and in Figure

pected, the expression of Bmal1, Per1, and Per2 genes was rhyth-

S1 (absolute values). Short-chain acylcarnitines: acetylcarnitine, bu-

mic under both diets and rhythms were enhanced by CR (Figure 1f).

tyrylcarnitine, and hexanoylcarnitine were significantly upregulated

Phases of clock gene expression were not significantly affected by

by CR. Daily average levels of acetylcarnitine and butyrylcarnitine

CR. We also assayed phosphorylation of ribosomal S6 protein as a

were induced by more than tenfolds, and hexanoylcarnitine was

surrogate marker of mTORC1 activity. In agreement with previous

induced by about 3-folds. Medium-chain (C8-C12) acylcarnitines

reports (Tulsian et al., 2018), S6 phosphorylation oscillates during

were not significantly affected with an exception for 2-fold induc-

the day in the liver on both diets (Figure 1g,h). The peak of S6 phos-

tion for C12-acylcarnitine. The effect of CR on long-chain acylcar-

phorylation was between ZT14 and ZT18 for both diets. Further in-

nitine (C14–C20) was not uniform. C14 acylcarnitines were induced

vestigation is required to determine whether the observed changes

by about 2 times, and C16:2 was slightly induced. C16, C16:1, C18,

in acylcarnitine rhythms are linked with changes in the circadian

and C18:1 acylcarnitines were not significantly affected. Finally,

clock or mTOR signaling rhythms.

C18:2-acylcarnitines and C20:4 acylcarnitines were reduced by CR.
CR also resulted in 70% increase in free carnitine and 3-fold increase
in total liver carnitines (Figure 1c). Thus, CR liver either increased the
synthesis or the uptake of free carnitine. Interestingly, only 28% of

2.2 | CR-induced expression of long-chain fatty
acid beta-oxidation enzymes in mitochondria

cellular carnitine was free in CR contrary to 50% of free carnitine in
AL liver (Figure 1c).

Accumulation of acetylcarnitine is an indication of increased fatty

The second major effect of CR was on acylcarnitine daily rhythms.

acid oxidation, which agrees with previously reported increases

Daily profiles of absolute values for several acylcarnitines are shown

in whole body fat oxidation under CR (Bruss et al., 2010). Beta-

in Figure 1b and Figure S2A. While many acylcarnitines demon-

oxidation occurs in mitochondria and peroxisomes. The chain of

strated significant changes throughout the day, only a few of them

biochemical reactions is similar between these two organelles,

demonstrated circadian rhythms (Table S2). Figure 1e shows around

but the enzymes involved in the process are different (Figure 2a).

the clock phase distribution for rhythmic acylcarnitines. AL mice eat

We monitored the expression of enzymes responsible for fatty

around the clock, and they have two major meals, one meal is around

acid activation, transport to mitochondria and oxidation in the

ZT12–ZT16 and another meal around ZT20–ZT2 (Velingkaar et al.,

liver by Western blotting. The expression of long-chain acyl-CoA

2020). We analyzed if some acylcarnitines oscillated with a 12-h pe-

synthetase 3 (ACSL3) was slightly induced by CR (Figure 2b and

riod. Indeed, 9 acylcarnitines demonstrated 12-h rhythms in AL liver

Figure S3). Surprisingly, CR did not affected the expression of

F I G U R E 2 CR resulted in increased oxidation of long-chain fatty acids in mitochondria. (a) Scheme of fatty acid beta-oxidation in
mitochondria and peroxisomes. Adipose tissue originated long-chain fatty acids (C14-C20) are activated to long-chain Acyl-CoAs and
oxidized through cyclic reaction cascade in mitochondria or peroxisomes. Enzymes controlling corresponding steps in beta-oxidation are
shown in the same color. The first step of mitochondrial beta-oxidation is catalyzed by four enzymes from the Acyl-CoA Dehydrogenase
(ACAD) family. These enzymes have substrate preferences: very-long-chain ACAD C14-20, long-chain ACAD (C10–C16), medium-chain
ACAD (C6–C10), and short-chain ACAD (C4–C6). Long-chain acyl-CoAs are oxidized first through the reactions controlled by VLCAD
and LCAD, resulting in chain shortening for subsequent oxidation by MCAD and, finally, by SCAD. See further details in the text. (b)
Representative Western blotting of beta-oxidation enzymes in the liver of AL (marked as a) and CR (marked as c) mice, across the day. Every
line represents pooled samples (n = 3). Light and dark bars represent light and dark phases of the day. (c) Protein and (d) mRNA expression,
from left to right: first panels—VLCAD protein and corresponding Acadvl gene; second panels—LCAD protein and corresponding Acadl
gene; (c) third panel—ACOT3/4 protein, and (d) third panel Acot4 and fourth panel Acot3 genes (data represented as average±STD, n = 3 per
time point per diet). (e) Examples of daily rhythms of short-chain (C6) and long (C14 and C18) hydroxy-acylcarnitines in the liver of AL (blue
lines) and CR (red lines) mice (data represented as average±STD, n = 4 per time point per diet). (f) Fold change in ratio between hydroxyacylcarnitines and corresponding acylcarnitines in CR liver. The ratio between hydroxy-acylcarnitine and corresponding acylcarnitine was
set as one for AL (n = 24 per diet). Acylcarnitine species are annotated as following [number of carbon atoms]:[number of double bonds]. *—
statistically significant difference, p < 0.05 t test. #—statistically significant effect of diet, p < 0.05, two-way ANOVA. Shadowed area on the
graphs or dark bar above the Western blot represents dark phase of the day, the light was on at ZT0, and the light was off at ZT12. Tables
S4, S5, and S6 contain statistics from anova and student's t test for qPCR, Western blot, and hydroxy-acylcarnitine results, respectively
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represented as average±STD, n = 3 per time point per diet). (h) Ketone bodies (beta-hydroxybutyrate) in the blood (data represented as
average±STD) of AL (n = 6) (blue bars), and CR (n = 8) (red bars) at ZT14 and ZT18. (i) mRNA expression for Crat gene (data represented
as average±STD, n = 3 per time point per diet). Light and dark bars represent light and dark phases of the day. *—statistically significant
difference, p < 0.05, t test. #—statistically significant effect of diet, p < 0.05, two-way ANOVA. Shadowed area on the graphs or dark bar
above the Western blot represents dark phase of the day, the light was on at ZT0, and the light was off at ZT12. Table S7 contains statistics
from ANOVA and student's t test for acyl-CoAs
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CPT1 (Figure 2b and Figure S3), which is considered as one of the

Figure S4A. Most of the detected 3-hydroxy-acylcarnitines demon-

key enzymes in mitochondria fat oxidation (Eaton, 2002). CPT1 ac-

strated changes through the day in both diets, several of them were

tivity is also regulated by malonyl-CoA, but malonyl-CoA level was

rhythmic with 24-h or 12-h periods (Figure S4B and Tables S2 and

not affected by CR (Figure 3e). CR induced the expression of both

S3). Daily average levels of 3-hydroxy-acylcarnitines are presented

VLCAD and LCAD at multiple times around the clock (Figure 2b,c).

in Figure S5. There was a statistically significant increase in several

The expression of HADHB, a subunit of MTP, that catalyzes the

long-chain 3-hydroxy-acylcarnitines (C14-OH, C14:1-OH, C18-OH,

last step of long-chain acyl-CoA oxidation was not significantly af-

and C18:1-OH), and C16:1-OH demonstrated a tendency to increase

fected. The expression of MCAD was slightly, but not significantly,

(Figure S5C). All detected medium-chain 3-hydroxy-acylcarnitines

upregulated, and the expression of SCAD was not affected by CR.

(C8:1-OH, C10-OH, C12-OH, and C12:1-OH) were modestly induced

The expression of HADHSC and ACAA2 that catalyze the next

by CR (Figure S5B). 3-hydroxy-hexanoylcarnitine was reduced by CR

steps in oxidation of medium- and short-chain acyl-CoA was also

in a time of the day-dependent manner (Figure S5A and Figure 2e).

not significantly affected by CR. (Figure 2b). Thus, the effect of CR

3-hydroxybutyrylcarnitine was induced, but the induction was not as

on fatty acid metabolic enzyme expression was selective, which

strong as the induction in butyrylcarnitine (Figure S5A and Figure 1a).

changed the balance between different enzymes and contributed

To calculate the ratio between 3-hydroxy-acylcarnitine and acylcarni-

to the differential acylcarnitine profile.

tine, the concentration of 3-hydroxy-acylcarnitine in the sample was

Peroxisomes are another site for beta-oxidation (Figure 2a)

divided on the concentration of cognate acylcarnitine in the same

(Fransen et al., 2017). ACOX1 is a peroxisomal dehydrogenase and

sample. The calculated ratio across the day is shown in Figure S6.

functional analog of ACADs, where it catalyzes the first step of acyl-

Figure 2f represents the fold change for the ratio between hydroxy-

CoA beta-oxidation. In contrast with mitochondrial dehydrogenases,

acylcarnitine and their cognate acylcarnitine (the ratio was set up as

CR did not increase ACOX1 expression and even slightly down regu-

1, shown as dotted line, for every acylcarnitine in AL). CR resulted in

lated the expression (Figure 2b). The expression of peroxisomal thio-

several fold increase for long-chain carnitines (C16:1, C18, C18:1 and

esterases ACOT3 and/or ACOT4 (the antibodies cannot distinct these

C18:2) and a couple medium-chain carnitines (C10 and C8:1) and sev-

two highly homologous enzymes) was increased under CR. ACOTs in-

eral fold decrease for short-chain carnitines (C4 and C6). Thus, liver

activate acyl-CoAs by removing the CoA group (Tillander et al., 2017).

3-hydroxy-acylcarnitines were not accumulated in proportion to their

Thus, the expression of the first committed enzyme in peroxisomal

cognate acylcarnitine, which further supports significant changes in

beta-oxidation was downregulated, and the expression of inactivation

fatty acid oxidation induced by CR.

enzymes were increased by CR. We concluded that it is unlikely that
peroxisomal oxidation of fatty acids was significantly induced under
CR, and the majority of increased acylcarnitines are generated in the
mitochondria. Peroxisomal beta-oxidation is not coupled with ATP

2.4 | CR increases accumulation of short-chain
acyl-CoA

production; instead, hydrogen peroxide and heat are generated. It is
not a surprise that with limited resources under CR, peroxisomal beta-oxidation is not induced.
To understand the mechanisms of CR-induced changes in be-

Acylcarnitines are in dynamic balance with their cognate acyl-CoAs
(Brass & Hoppel, 1980). The increased concentration of short-chain
acylcarnitines is an indication of increased levels of associated acyl-

ta-oxidation enzymes, the mRNA expression for their genes was

CoAs. We directly assayed levels of several short acyl-CoAs and

assayed. The expression of Acadvl (encodes VLCAD), Acadl (encodes

long-chain palmitoyl-CoA in the liver. In agreement with acylcar-

LCAD), and peroxisomal Acot3 and Acot4 was significantly induced

nitine data CR resulted in significant upregulation of acetyl-CoA,

by CR in a time of the day-dependent manner (Figure 2d). mRNA

butyryl-CoA, and hexanoyl-CoA at all six time points across the

expression was in agreement with protein expression and with pub-

day (Figure 3a). Free (Figure 3b) and total (Figure 3c) CoAs were in-

lished data on polysome association (Makwana et al., 2019). Thus,

creased by several folds in CR liver suggesting either increased pro-

the changes in mRNA expression might provide a mechanistic expla-

duction or reduced degradation of CoA. Interestingly, free and total

nation for increased protein expression.

CoAs were significantly affected by CR but there was no significant
difference in free to total ratio between the diets (Figure 3d).

2.3 | CR increased accumulation of long-chain
3-hydroxy-acylcarnitines

The conversion between acyl-CoAs and acylcarnitines in the
mitochondria is regulated by two mitochondrial carnitine acyltransferases: CPT2 and CrAT. CPT2 acts on long-chain and medium-chain
acyl-CoAs (Kerner & Hoppel, 2000), and CrAT acts on short-chain

3-hydroxy-acyl-CoAs are intermediates of beta-oxidation (Su et al.,

and medium-chain acyl-CoAs including acetyl-CoA (Seiler et al.,

2005). Corresponding acylcarnitines are formed by CPT2 (Ramsay,

2015). The expression of both enzymes was significantly upreg-

2000). Several 3-hydroxy-acylcarnitines were detected in the liver of

ulated by CR (Figure 3f,g). Crat mRNA expression was also signifi-

AL and CR mice. Daily profiles of 3-hydroxy-hexanoylcarnitine (C6-

cantly upregulated in CR liver (Figure 3i). Cytoplasmic short-chain

OH), 3-hydroxy-myristoylcarnitine (C14-OH), and 3-hydroxy-octade-

acyl-CoA synthases (ACSS2) convert acetate to acetyl-CoA, and the

cenoyl (C18:1-OH) are shown in Figure 2e, while others are shown in

expression of ACSS2 was not significantly affected by CR (Figure 3f).
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F I G U R E 4 Caloric restriction affected protein acetylation in the liver. (a) Representative Western blotting of protein acetylation in total
lysates from the liver of AL (marked as a) and CR (marked as c) mice. (b) Quantification of several major bands from (a), upper panel—band I,
middle panel—band II, lower panel—band III. (c) Western blotting of cytoplasmic (left), nuclear (middle), and mitochondrial (right) fractions of
the liver, tissues were collected at ZT14. Cellular fraction separation was confirmed by Western blotting for GAPDH (cytoplasm), Histone H3
(nucleus), and VDAC1 (mitochondrial). (d) Effect of CR on acyl-CoA metabolism (model). After activation and transport to mitochondria longchain fatty acids are oxidized by mitochondrial membrane associated VLCAD and VCAD, which expression is increased under CR. As a result,
short-chain acyl-CoAs are accumulated in the CR liver. Mitochondrial acyl-CoAs and acylcarnitines are in a dynamic equilibrium controlled
by CPT2 and CrAT, which expression is increased by CR. Short-chain acylcarnitines can travel from mitochondria to cytoplasm, where they
can be converted back to acyl-CoAs. Elevated acetyl-CoA can be used for ketone body production and for regulation of metabolism, either
through the direct suppression of PDH and activation of PC or through protein acetylation. Short-chain acylcarnitines may also travel into
the bloodstream to be used by other tissues for energy production. Components with red text are upregulated under CR
We also calculated the ratio between acylcarnitines and acyl-CoA.

2.5 | CR affected blood ketone bodies

The results are presented in Figure S7. Interestingly, the ratio between acyl-CoA and cognate acylcarnitine was changed across the

Acetyl-CoA is a precursor for several biochemical reactions, and it

day for both diets and the profiles were different for different acyls.

can serve as a signaling molecule (Pietrocola et al., 2015). High levels

These results suggest that reversible interconversion between acyl-

of acetyl-CoA are frequently associated with increased fat biosyn-

CoAs and acylcarnitines was not in equilibrium. The changes in CrAT

thesis. Malonyl-CoA is a rate-limiting precursor for fatty acid bio-

and CPT2 expression might contribute to this dynamic balance.

synthesis and regulator of CPT1 activity. The level of malonyl-CoA
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was not increased and even reduced in the CR liver (Figure 3e),

Figure S8). Acadl, Acadvl, Crat, Hadhb, Slc25a20, Acot3, and Acot4

which was not surprising. Synthesis of fatty acids from acetyl-CoA

were significantly induced at several time points. Acadm and Cpt2

that were produced as a result of fatty acid oxidation would be a

were induced only at one time point. Diet had a significant effect

futile cycle. Acetyl-CoA is a precursor for ketone body production

on Acads, Cpt1a, and Hmgcs2 expression, but the difference did not

(Pietrocola et al., 2015). Blood ketones were assayed at two time

reach significance at any time point (see details of statistical analysis

points at ZT14 (before feeding CR mice) and at ZT18 (4 h after feed-

in Table S4). A ketogenic diet is a popular dietary intervention to im-

ing CR mice). Blood ketone bodies were low at both time points in

prove metabolism, and there are some parallels between CR and ke-

AL mice (Figure 3h). In CR mice, blood ketone bodies were several

togenic diet. Recently, an analysis of the liver transcriptome around

folds higher compared with AL at ZT14, and they were as low as AL

the clock in mice on ketogenic diet concluded that PPARα transcrip-

at ZT18. Interestingly, acetyl-CoA levels were several folds higher in

tional activity is induced by ketogenic diet (Tognini et al., 2017). We

the CR liver compared with AL at both time points; thus, increased

analyzed available RNAseq data from Tognini et al and compared it

acetyl-CoA contributed to the increased blood ketones in CR, but

with the expression in our study. The expression of these PPARα

additional regulations also exist.

targets is strongly upregulated by ketogenic diet at all time points
around the clock, which is in contrast with CR that have a time of the

2.6 | CR increased protein acetylation in the liver

day-dependent effect and overall minimal induction (Tognini et al.,
2017). Protein expression was not reported; therefore, it is unclear
if ketogenic diet induced mRNA expression will translate to the pro-

Acetyl-CoA is a cofactor for protein acetylation, and increased level

tein level. Thus, CR and ketogenic diet have significantly different

of acetyl-CoA correlates with increased protein acetylation. It was

effects on the expression of fat oxidation enzymes and PPARα tran-

previously reported that CR increases protein acetylation in mito-

scriptional targets.

chondrial (Schwer et al., 2009) and total (Sato et al., 2017) liver extracts. Protein acetylation in the liver was measured with antibodies
to acetyl-lysine (Figure 4a). Intensity of multiple bands was increased

3
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DISCUSSION

several folds in CR liver across the day. Quantitative data for several bands are shown in Figure 4b. To determine whether increased

Fatty acid beta-oxidation is the main mechanism of energy produc-

protein acetylation is exclusively in the mitochondria, liver extracts

tion under CR, and a strong flux of fatty acids to the liver is expected

were fractionated (Figure 4c). The quality of fraction separation was

under CR (Anderson & Weindruch, 2010; Bruss et al., 2010). Profiling

confirmed with known markers histone H3 for the nucleus, GAPDH

of acylcarnitines is a widely accepted method to detect changes in

for the cytoplasm and VDAC1 for the mitochondria. Protein acetyla-

fatty acid oxidation (El-Gharbawy & Vockley, 2018). We performed

tion was measured in cytoplasmic, nuclear, and mitochondrial frac-

a comprehensive circadian analysis of acylcarnitines and unexpect-

tions separately at one time point of the day (ZT14). The increase in

edly found a selective effect of CR on acylcarnitine and acyl-CoA

acetylation was evident in all fractions. Interestingly, the increase in

rhythms in the liver. Acetylcarnitine and acetyl-CoA levels were pre-

acetylation was not absolute; for example, there was no increase in

viously assayed in CR with mixed results. Acetylcarnitine is elevated

the intensity of 17-kDa band in nuclear fractions. Protein acetyla-

by acute CR in human serum (Collet et al., 2017), which agrees with

tion can be catalyzed by protein acetylases, or it can be enzyme-

our data. At the same time, reduced acetyl-CoA was observed by

independent (Pietrocola et al., 2015), and an increase in acetyl-CoA

(Hebert et al., 2013) and (Perry et al., 2018). Finally, Gopalan et al re-

shall stimulate both. At the same time, protein deacetylases have

ported no significant effect on acetylcarnitine levels (Gopalan et al.,

substrate preferences, and observed differences in acetylation pat-

2016). We do not know what exactly causes the difference between

tern might be due to the regulatory change of protein deacetylase

our study and cited studies: Hebert et al performed analysis only in

activity, which warrants further study.

one sample, Perry et al used a diabetic rat model and severe 4-day
CR, Gopalan et al used high-fat diet induced obesity rat model and

2.7 | CR differentially affected expression of
PPARα transcriptional targets

CR that was implemented with high-fat diet. Methods of acetyl-CoA
analysis were different between studies. Data on protein acetylation
under CR from our study and two other studies (Sato et al., 2017;
Schwer et al., 2009) are in line with the increase in acetyl-CoA in CR

PPARα is a transcriptional factor and master regulator of liver fat

liver. Gopalan et al also reported an induction for a few long-chain

metabolism (Kersten et al., 1999). It was hypothesized that PPARα

acylcarnitines; however, the effect was significant for 15% CR but

activity might be induced by CR (Masternak & Bartke, 2007), but

not 30% CR (Gopalan et al., 2016). To the best of our knowledge,

it was never directly demonstrated. Several of the upregulated

the effect of CR on acylcarnitine profile in healthy animals has not

fat oxidation enzymes are known targets of PPARα; therefore, we

been reported.

decided to investigate whether several other PPARα targets were

The expression of several fat oxidation genes is affected by CR

affected in CR liver. The expression for all assayed PPARα transcrip-

according to several transcriptomic studies (Swindell, 2009), but

tional targets was significantly affected in CR liver (Figure 2d, 3i and

protein expression was not reported. The expression of CPT1 and
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its physiological regulator malonyl-CoA were not significantly af-

a significant induction in the expression of CrAT under CR condi-

fected by CR. CR significantly increased the expression of VLCAD

tions. High level of acetylcarnitine and increased expression of CrAT

and LCAD, which are enzymes involved in the initial steps of fatty

suggest that the carnitine shuttle pathway of export was induced in

acid beta-oxidation, but did not increase the expression of down-

CR. Another pathway for acetyl-CoA export from mitochondria is

stream enzymes such as trifunctional protein subunits or any of

“citrate–malate–pyruvate shuttle.” It is known that citrate transport

the enzymes involved in medium and short-chain beta-oxidation.

plays an important role in fat biosynthesis when there is high carbo-

These results are in contrast with the effect of ketogenic diet

hydrate load. It is hypothesized that this pathway is reduced in fast-

which results in significant upregulation of mRNAs for all fat ox-

ing due to depletion of oxaloacetate for gluconeogenesis (Pietrocola

idation enzymes (Tognini et al., 2017). Of note, only mRNA data

et al., 2015). It is unknown if the citrate shuttle is affected in CR.

are available from Tognini et al, and the effect of ketogenic diet on

Therefore, we cannot exclude that citrate transport contributes to

protein expression was not reported. CR and ketogenic induced

acetyl-CoA export. Finally, it was suggested that increased acetate

changes in acylcarnitine profiles were also different. Medium and

is responsible for increased acetyl-CoA in CR liver (Sato et al., 2017),

long-chain, but not short-chain acylcarnitines, accumulate in the

but it was not experimentally demonstrated.

liver of mice after 4 days on ketogenic diet (Lee et al., 2016). Thus,

What might be a physiological significance for the increase of

CR and ketogenic diet differently reprogram fat metabolism. CR

short-chain acyl-CoAs, acetyl-CoAs and corresponding acylcarni-

did not simply increase fat oxidation; rather, the balance between

tines? What might be their roles in CR health benefits? Based on our

upstream and downstream enzymes was significantly shifted,

data, we proposed a following model on CR-induced changes in fat

which in turn might contribute to the observed changes in the

oxidation and short-chain acyl-CoA homeostasis and how it might

acylcarnitine profile.

impact metabolism and physiology (Figure 4d).

We also compared the acylcarnitine profiles in CR liver with
acylcarnitine profiles in tissues and body fluids from other studies

1. Acetyl-CoA and other short-chain acyl-CoAs can be used for

using animal models and clinical cases of fatty acid oxidation defi-

protein posttranslational modifications. Our data expanded the

ciency. SCAD deficient mice have increased hexanoylcarnitine in

results of several previous reports on CR and protein acetylation.

the liver, but butyrylcarnitine and acetylcarnitine are not increased,

CR induces protein acetylation in the mitochondria (Schwer et

and medium and long-chain acylcarnitines, which are upstream in

al., 2009), while the effect might be protein specific (Hebert et

beta-oxidation pathways, are also significantly upregulated (Ghosh

al., 2013), and total (Sato et al., 2017) liver extracts. Our results

et al., 2016). MCAD deficient mice have increased accumulation of

suggest that acetylation of cytoplasmic and nuclear proteins is

C6-C10 acylcarnitines and no increase in short-chain acylcarnitines

also induced in the liver by CR (Figure 4c). In agreement with

(Tolwani et al., 2005). LCAD deficient mice have almost opposite

our data, 24-h fasting results in increased protein acetylation

acylcarnitine profile to the profile of CR: increased long-chain acyl-

in the liver of wild-type mice but not in the liver of mice

carnitines, reduced level of 3-hydroxy-acylcarnitines (Kurtz et al.,

deficient for LCAD (Pougovkina et al., 2014). Thus, the ac-

1998; Van Vlies et al., 2005), and no accumulation of short-chain

tivity of long-chain acyl-CoA dehydrogenases is necessary for

acylcarnitines. Trifunctional protein deficiency results in accumula-

increased acetyl-CoA production during fasting and, probably,

tion of both long-chain hydroxy-acylcarnitine and long-chain acyl-

under CR, which needs to be tested in the future.

carnitines, but there is no accumulation of short-chain acylcarnitines

2. Fatty acids are natural ligands for transcriptional factors from the

(Van Hove et al., 2000). Importantly, in each discussed fatty acid

PPAR family, including PPARα and different ligands affect differ-

oxidation deficiency disorder the level of acetylcarnitine is not in-

ent subsets of targets (Kersten et al., 1999). Here, we found that

creased, which agrees with reduced beta-oxidation (Ghosh et al.,

CR differentially regulated the expression of several canonical

2016). Thus, while short-chain acylcarnitines were accumulated in

PPARα targets (Mandard et al., 2004) in the liver. Changes in the

CR, the profile is significantly different from fat oxidation deficiency.

acyl profile induced by CR might modulate PPARα activity and

Increased acetyl-CoA suggests that production did not match

contribute to changes in the transcriptional landscape under CR.

consumption. Acetyl-CoA can be consumed through TCA cycle,

It might also affect a crosstalk with other transcriptional regula-

ketone body production or exported from mitochondria either as

tors, such as circadian clock transcriptional factors (Eckel-Mahan

citrate or as acetylcarnitine. Other short-chain acyl-CoAs can also

et al., 2013; Mukherji et al., 2015).

be exported as cognate carnitines. We do not know if acetyl-CoA

3. Finally, acylcarnitines can travel in the blood stream, and they

through TCA cycle was affected by CR. Blood ketones were induced,

can be released or consumed by tissues depending on energy

at least at ZT14, in agreement with increased acetyl-CoA. Protein

demands. For example, skeletal muscles efflux acetylcarnitine

acetylation in different cellular compartments was increased, impli-

at rest and uptake acetylcarnitine during the physical activity

cating acetyl-CoA export from the mitochondria. One export path-

(Seiler et al., 2015; Simcox et al., 2017). Changes in acylcarnitine

way relies on the generation of acetylcarnitine by mitochondrial

flux might contribute to metabolic flexibility of the tissues during

CrAT and export via the carnitine shuttle. After export from the mi-

nutrient and energy stress (Muoio, 2014). Therefore, under CR

tochondria, acetylcarnitine is converted back to acetyl-CoA by cy-

conditions the liver may provide energy supply to other tissues in

toplasmic CrAT (Altamimi et al., 2018; Seiler et al., 2015). There was

the form of short-chain acylcarnitines.
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4. Finally, acetyl-CoA and other short-chain acyl-CoAs may also act
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4.3 | Analysis of mRNA expression

as signaling and regulatory molecules. High levels of short-chain
acyl-CoAs are associated with reduced glycolysis and increased

Total RNA was extracted from frozen liver tissue using TRIzol ac-

gluconeogenesis. For example, pyruvate dehydrogenase activity

cording to manufacturer's instructions. After quantification and

is suppressed, and pyruvate carboxylase activity is stimulated by

quality check of total RNA by electrophoresis, total RNA was re-

acetyl-CoAs, thus, redirecting pyruvate from TCA cycle to gluco-

verse transcribed with SuperScript IV Reverse Transcriptase. Real-

neogenesis, which is important during prolonged fasting in CR.

time quantitative PCR was performed using iTaq Universal SYBR
Green Supermix (Bio-Rad). 18S rRNA expression levels were used

Limitations of the study: acetyl-CoA is generated as a result of

for normalization. Fold change was determined by ΔΔCt method.

various catabolic processes. While our data strongly implicate that
beta-oxidation is the main contributor to the increase in acetyl-CoA,
it needs to be directly tested. Similarly, it was not directly assayed

4.4 | Analysis of protein expression

if increased butyryl-CoA and hexanoyl-CoA were produced through
the oxidation of stored triglycerides or from gut microbiota derived

Total liver lysates were prepared with lysis buffer (1 M Tris Base pH

short-chain fatty acids. Muscle and adipose tissue play an important

7.5, 5 M NaCl, 0.5 M EGTA, 0.5 M EDTA, Triton-X, 0.1 M Na4P2O7,

role in whole body metabolism, but this study was limited to the liver.

1 M β-glycerophosphate, 1 M Na3VO 4) containing protease and

There is evidence that the outcome might be different in different tis-

phosphatase inhibitor cocktails (Sigma). For fractionated protein ex-

sues. Indeed, CR increases protein acetylation in the liver mitochon-

tracts, 30 mg of liver was homogenized with Dounce homogenizer

dria, but in several other tissues the effect is minimal if any (Schwer

in Buffer A (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM

et al., 2009). Changes in protein acetylation may be due to changes in

DTT, 0.05% NP40, 0.1 M Na4P2O7, 1 M β-glycerophosphate, 1 M

the activities of protein deacetylases and acetylases, which were not

Na3VO4, and protease and phosphatase inhibitor cocktails) and cen-

assayed. At the same time, it is expected that activities of deacety-

trifugated at rcf: 960 g for 5 min at 4°C. The pellet contained the

lases will be increased under CR, and activities of, at least some,

nuclear fraction, and supernatant was centrifugated at rcf: 6800 g

acetylases will be decreased due to increased blood ketones.

for 5 min for separation of cytosolic (supernatant) and mitochondria (pellet) fractions. After SDS-PAGE, proteins were transferred

4
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onto PVDF membrane. For list of antibodies, see Supplemental Key
Resources Table. Quantification of images was done using Image
Studio Lite software.

Detailed methods and list of reagents are available in Appendix S1.

4.1 | Animals

4.5 | Sample Preparation for Acylcarnitine and
acyl-CoA Analysis

All experiments involving animals were conducted in accordance

Internal standard stock solutions were prepared as follows:

with Federal and University guidelines, and all procedures were ap-

Acylcarnitine Internal Standard Mix (1520 nM d9-carnitine, 380 nM

proved by IACUC, Cleveland State University. C57BL/6J mice were

d3-acetylcarnitine, 76 nM d3-propionylcarnitine, 76 nM d3-butyryl-

maintained on 12 h light: 12 h dark cycle (LD12:12). Mice used in

carnitine, 76 nM d9-isovalerylcarnitine, 76 nM d3-octanoylcarni-

the experiments were 12–13 weeks of age at the start of the ex-

tine, 76 nM d9-myristoylcarnitine, 152 nM d3-palmitoylcarnitine)

periments. Animals were maintained in groups of three–four animals

in methanol. 13C2-acetyl-CoA (1000 ng/ml in 1:1 v/v methanol:5%

per cage on 5008 LabDiet (proteins 26.5%, fat 16.9%, carbohydrates

acetic acid).

56.5%). CR mice received food once per day 2 h after the lights were

All sample preparations were performed on ice. Mouse liver

turned off (ZT14). At 5 months of age, liver tissues were collected

tissues (~40 mg frozen mass stored at −80°C) were spiked with

across the day, every 4 h and immediately frozen and kept at −80°C

10 µl of NSK-B acylcarnitine internal standard mix (Cambridge

for subsequent processing.

Isotope Labs) and 10 µl of 1000 ng/ml 13C 2-acetyl-CoA (Sigma
Aldrich). Each tissue was homogenized in 1 ml of “Extraction

4.2 | Blood Glucose and
β-hydroxybutyrate detection

Matrix” (1:1 v/v) methanol:5% acetic acid (aq) using a VWR pellet
mixer and centrifuged at 12 k rpm for 5 min. The supernatant was
transferred to a 13 mm glass tube. The remaining tissue was homogenized and centrifuged again in 1 ml of Extraction Matrix. The

Blood for the analysis was collected through the tail vein at time

combined supernatants were dried under N2 and reconstituted in

points ZT2, 6, 10, 14, 18, and 22. Blood ketones were measured

200 µl of Extraction Matrix. A total of 50 µl was aliquoted for acyl-

as β-hydroxybutyrate level using Precision Xtra Blood Glucose and

carnitine analysis, and the remaining kept at −80°C for acyl-CoA

Ketone meter (Abbott Laboratories, IL, USA).

analysis. The 50 µl aliquot was dried under N2 and derivatized by

12 of 14
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addition of 60 µl butanol-1-HCl (Sigma Aldrich) incubated at 80°C

injection with (3:2:1:0.2 v/v/v/v) acetonitrile:isopropanol:water:p

for 20 min. The sample was dried under N2 and reconstituted in

hosphoric acid. Gradient elution: 100 mM ammonium formate in

60 µl of (80:20:0.1 v/v/v) acetonitrile:water:formic acid. The sam-

98:2 v/v water:acetonitrile (mobile phase A) and 5 mM ammonium

ples were stored at −80°C. For analysis, frozen samples were kept

formate in 95:5 v/v acetonitrile:water. (mobile phase B). Time pro-

on ice and transferred to HPLC vials with 100 µl glass inserts after

gram: 1 min hold at 2.5% B, linear increase to 55% B at 4 min, and

vortex mixing.

linear increase to 98% B at 6 min. Hold at 98% B for 2 min followed
by re-equilibration at starting conditions for 7 min. Total run time

4.6 | Acylcarnitine Analysis by LC-MS/MS
Analysis was performed using a Shimadzu Nexera UHPLC coupled

was 15 min per sample.

4.8 | Quantification and Statistical Analysis

to a SCIEX QTrap 5500 mass spectrometer. The SCIEX Turbo V ESI
source was operated in positive mode with curtain gas set to 40

Data for both diets were analyzed using ordinary two-way ANOVA

psi, CAD gas set to high, IS voltage 4500 V, temperature 700°C,

(multiple comparison correction was done using the Bonferroni

GS1 and GS2 gases at 50 psi and 45 psi, respectively. Compound-

method). All statistical analysis was performed using GraphPad

specific parameters were optimized by direct infusion of a 1 µM

Prism 7.0 (San Diego, CA). Rhythms analysis was performed in

mixture of butylated free carnitine, acetylcarnitine, butyrylcarni-

R-studio using MetaCycle package (Wu et al., 2016). At least three

tine, octanoylcarnitine, and palmitoylcarnitine in 0.1% formic acid

biological replicates have been used for every time point and every

in acetonitrile. Butylated acylcarnitines fragment similarly produc-

diet. Exact number of biological samples for every experiment is re-

ing a common fragment m/z 85 in positive mode. Therefore, the

ported in the Figure legends. Data are shown as Mean ± SD. p ≤ 0.05

MRM transitions for acylcarnitines of interest were measured by

was considered as statistically significant difference.

monitoring the parent ion [M + H]+ > m/z 85.1,2 Separation was
achieved using a Waters XBridge BEH C18 (75 × 2.1 mm, 2.5 μm)

AC K N OW L E D G M E N T

column heated to 40°C with flow rate 0.6 ml/min. The autosam-

This work was supported by U.S. National Institutes of Health/

pler was kept at 4°C and sample injection volume set to 1 µl. The

National Institute on Aging Grant R01AG039547 and funds from the

needle was rinsed externally after each injection with acetonitrile.

Center for Gene Regulation in Health and Disease (Cleveland State

Gradient elution: 0.1% formic acid in HPLC-grade water (mobile

University) to R.K.

phase A) and 0.1% formic acid in acetonitrile (mobile phase B).
Time program: 1 min hold at 20% B, linear increase to 37% B at

C O N FL I C T O F I N T E R E S T

8 min, and linear increase to 100% B at 22 min. Hold at 100% B for
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4 min followed by re-equilibration at starting conditions for 4 min.
Total run time was 30 min per sample.
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